Biopharma News

Aug 28, 2013
By BioPharm International Editors
Amarin released the submission of an sNDA to FDA seeking approval for Novasep Group.
Aug 26, 2013
By BioPharm International Editors
Vical's restructuring will leave the company with approximately 74 employees.
Aug 26, 2013
By BioPharm International Editors
Santaris Pharma and Shire have extended their partnership in the rare genetic disease space.
Aug 14, 2013
Amgen, Servier collaborate ivabraline and other cardiovascular products.
Aug 08, 2013
By BioPharm International Editors
ScinoPharm Changshu Pharmaceuticals and Sundia MediTech form an alliance for contract research and manufacturing services in mainland China.
Aug 06, 2013
By BioPharm International Editors
iQur announced that it has been granted 5 million EUR ($6.6 million) by the European Union Framework 7 fund to develop a universal influenza vaccine.
Aug 06, 2013
By BioPharm International Editors
A loan from the Province of Nova Scotia will support Immunovaccine's clinical studies through 2016.
Aug 06, 2013
By BioPharm International Editors
The licensed cell line combines BioWa's engineered glycosylation Potelligent Technology with Lonza's GS Gene Expression System.
Aug 06, 2013
By BioPharm International Editors
uniQure B.V. announced it has commenced build-out of a 55,000 ft2 US manufacturing plant in Lexington, Mass.
Jul 23, 2013
By BioPharm International Editors
Immunocore Limited has entered into a partnership with GlaxoSmithKline for multiple novel targets not addressable using antibody-based technologies.
native1_300x100
lorem ipsum